These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
577 related articles for article (PubMed ID: 29921293)
1. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin. Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293 [TBL] [Abstract][Full Text] [Related]
2. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway. Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296 [TBL] [Abstract][Full Text] [Related]
3. PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells. Zhang WJ; Luo C; Huang C; Pu FQ; Zhu JF; Zhu ZM Eur J Pharmacol; 2021 May; 899():174041. PubMed ID: 33737010 [TBL] [Abstract][Full Text] [Related]
4. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer. Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y Gene; 2022 Apr; 819():146240. PubMed ID: 35114275 [TBL] [Abstract][Full Text] [Related]
5. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway. Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126 [TBL] [Abstract][Full Text] [Related]
6. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis. Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706 [TBL] [Abstract][Full Text] [Related]
7. CCL20 and CXCL8 synergize to promote progression and poor survival outcome in patients with colorectal cancer by collaborative induction of the epithelial-mesenchymal transition. Cheng XS; Li YF; Tan J; Sun B; Xiao YC; Fang XB; Zhang XF; Li Q; Dong JH; Li M; Qian HH; Yin ZF; Yang ZB Cancer Lett; 2014 Jun; 348(1-2):77-87. PubMed ID: 24657657 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
9. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways. Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways. Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138 [TBL] [Abstract][Full Text] [Related]
11. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway. Zhang H; Sun JD; Yan LJ; Zhao XP Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215 [TBL] [Abstract][Full Text] [Related]
12. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation. Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935 [TBL] [Abstract][Full Text] [Related]
13. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530 [TBL] [Abstract][Full Text] [Related]
14. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis. Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161 [TBL] [Abstract][Full Text] [Related]
15. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways. Zhou J; Luo J; Gan R; Zhi L; Zhou H; Lv M; Huang Y; Liang G Recent Pat Anticancer Drug Discov; 2024; 19(4):543-555. PubMed ID: 38305308 [TBL] [Abstract][Full Text] [Related]
16. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131 [TBL] [Abstract][Full Text] [Related]
17. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling. Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761 [TBL] [Abstract][Full Text] [Related]
18. MIF/SCL3A2 depletion inhibits the proliferation and metastasis of colorectal cancer cells via the AKT/GSK-3β pathway and cell iron death. Huang G; Ma L; Shen L; Lei Y; Guo L; Deng Y; Ding Y J Cell Mol Med; 2022 Jun; 26(12):3410-3422. PubMed ID: 35567291 [TBL] [Abstract][Full Text] [Related]
19. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway. Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674 [TBL] [Abstract][Full Text] [Related]
20. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways. Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]